ORBIMED ADVISORS LLC 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:30 pm Sale | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 0 0.000% | -7,300,921 (Position Closed) | Filing |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 7,300,921 9.990% | 5,200,240 (+247.55%) | Filing |
| 2022-02-11 4:14 pm Purchase | 2021-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 2,100,681 8.000% | 433,856 (+26.03%) | Filing |
| 2021-02-12 4:41 pm Purchase | 2020-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 1,666,825 7.410% | 817,571 (+96.27%) | Filing |
| 2020-02-14 5:05 pm Purchase | 2019-12-31 | 13G | Applied Therapeutics, Inc. APLT | ORBIMED ADVISORS LLC | 849,254 4.590% | 849,254 (New Position) | Filing |